Pathology & Laboratory Medicine

Warning message

Selective filter "Related Faculty (field_biblio_faculty) (selective)" has limited the amount of total results. Please, review you query configuration.

Publications

Filter By Faculty

Filter by Principal Investigator

2005

Rubio CA, Nesi G, Zampi GC, de Ruiz PA, Jessurun J, Jónasson J, et al. Gastric ciliated metaplasia. A study of 3406 gastrectomy specimens from dwellers of the Atlantic and the Pacific basins. J Clin Pathol. 2005;58(6):605-10.

Ghinoi A, Mascia MT, Giuggioli D, Magistro R, Barbolini G, Magro CM, et al. Coexistence of non-specific and usual interstitial pneumonia in a patient with severe cystic scleroderma lung involvement and parvovirus B19 infection. Clin Exp Rheumatol. 2005;23(3):431-3.

Peng W, Zhang X, Mohamed N, Inghirami G, Takeshita K, Pecora A, et al. A DeImmunized chimeric anti-C3b/iC3b monoclonal antibody enhances rituximab-mediated killing in NHL and CLL cells via complement activation. Cancer Immunol Immunother. 2005;54(12):1172-9.

Fan G, Molstad M, Braziel RM, Standley M, Huang J, Rodgers W, et al. Proteomic profiling of mature CD10+ B-cell lymphomas. Am J Clin Pathol. 2005;124(6):920-9.

Williams TM, Hassan GS, Li J, Cohen AW, Medina F, Frank PG, et al. Caveolin-1 promotes tumor progression in an autochthonous mouse model of prostate cancer: genetic ablation of Cav-1 delays advanced prostate tumor development in tramp mice. J Biol Chem. 2005;280(26):25134-45.

Chen-Kiang S. Biology of plasma cells. Best Pract Res Clin Haematol. 2005;18(4):493-507.

Manazza AD, Bonello L, Pagano M, Chiusa L, Novero D, Stacchini A, et al. Follicular origin of a subset of CD5+ diffuse large B-cell lymphomas. Am J Clin Pathol. 2005;124(2):182-90.

Koutlas IG, Pambuccian SE, Jessurun J, J Manivel C, Gopalakrishnan R. Perivascular epithelioid cell tumor of the oral mucosa. Arch Pathol Lab Med. 2005;129(5):690-3.

A Ackerman B. Decline of a discipline: abetment by journals. J Cutan Pathol. 2005;32(3):254; author reply 254.

Gu Z, Rubin MA, Yang Y, Deprimo SE, Zhao H, Horvath S, et al. Reg IV: a promising marker of hormone refractory metastatic prostate cancer. Clin Cancer Res. 2005;11(6):2237-43.